| Male | Female | M vs F |
---|
| | |
---|
| Mean | SD | Mean | SD | P |
---|
|
---|
TJ78 | 3.71 | 6.75 | 4.55 | 7.79 | 0.215 |
SJ76 | 2.30 | 5.19 | 1.88 | 3.32 | 0.318 |
No. sites w/ enthesitis | 0.73 | 2.51 | 1.63 | 4.09 | 0.004 |
No. digits w/ dactylitis | 0.35 | 1.20 | 0.20 | 0.66 | 0.114 |
BSA | 4.88 | 11.12 | 3.03 | 6.67 | 0.074 |
PTGAVAS | 36.90 | 26.75 | 46.15 | 26.20 | 0.001 |
PGAVAS | 21.60 | 19.61 | 25.20 | 20.64 | 0.065 |
BMI | 27.85 | 4.52 | 26.94 | 5.44 | 0.060 |
CRP | 4.09 | 11.41 | 4.34 | 7.30 | 0.792 |
ESR | 10.78 | 12.93 | 14.15 | 12.65 | 0.010 |
DAS28_CRP | 2.53 | 1.17 | 2.84 | 1.08 | 0.012 |
PASDAS | 3.46 | 1.46 | 4.02 | 1.48 | 0.001 |
HAQ (<0.3) | 105 (40.1%) | 45 (22.7%) | 0.002 |
SF36 Σ phys comp | 41.40 | 10.55 | 38.27 | 9.68 | 0.001 |
SF36 Σ mental comp | 46.58 | 12.42 | 42.48 | 13.65 | 0.001 |
Actual use anti-TNF | 130 (50.2%) | 74 (37.8%) | 0.008 |
Any use of anti-TNF | 142 (54%) | 86 (43.4%) | 0025 |